GLCCI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.530000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.178600E-01
Normal-vs-Stage2
4.471600E-01
Normal-vs-Stage3
3.761000E-01
Normal-vs-Stage4
4.160200E-01
Stage1-vs-Stage2
3.837800E-01
Stage1-vs-Stage3
1.579220E-01
Stage1-vs-Stage4
3.414800E-01
Stage2-vs-Stage3
3.513400E-01
Stage2-vs-Stage4
6.804400E-01
Stage3-vs-Stage4
4.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.595600E-01
Normal-vs-AfricanAmerican
4.781400E-01
Normal-vs-Asian
3.564400E-01
Caucasian-vs-AfricanAmerican
8.503800E-01
Caucasian-vs-Asian
8.44160000000871E-05
AfricanAmerican-vs-Asian
8.562100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.388200E-01
Normal-vs-Female
4.723200E-01
Male-vs-Female
2.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.518000E-01
Normal-vs-Age(41-60Yrs)
4.834400E-01
Normal-vs-Age(61-80Yrs)
4.402400E-01
Normal-vs-Age(81-100Yrs)
4.329400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.629400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.770400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.975000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.624170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.087200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.787000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.228000E-01
Normal-vs-Daily Drinker
4.314600E-01
Normal-vs-Weekly Drinker
3.997600E-01
Normal-vs-Occasional Drinker
4.550800E-01
Normal-vs-Social Drinker
5.134400E-01
Non Drinker-vs-Daily Drinker
8.213600E-01
Non Drinker-vs-Weekly Drinker
5.672200E-01
Non Drinker-vs-Occasional Drinker
5.568600E-01
Non Drinker-vs-Social Drinker
1.417410E-01
Daily Drinker-vs-Weekly Drinker
4.169800E-01
Daily Drinker-vs-Occasional Drinker
7.053800E-01
Daily Drinker-vs-Social Drinker
2.582600E-01
Weekly Drinker-vs-Occasional Drinker
3.344200E-01
Weekly Drinker-vs-Social Drinker
1.051830E-01
Occasional Drinker-vs-Social Drinker
4.904400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.936400E-01
Normal-vs-Grade 2
3.818400E-01
Normal-vs-Grade 3
3.439800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.626200E-01
Grade 1-vs-Grade 3
1.470950E-01
Grade 1-vs-Grade 4
3.936400E-01
Grade 2-vs-Grade 3
8.649000E-01
Grade 2-vs-Grade 4
3.818400E-01
Grade 3-vs-Grade 4
3.439800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.362400E-01
Normal-vs-NonDiabetic
4.343600E-01
Diabetic-vs-NonDiabetic
9.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.851200E-01
Normal-vs-NoPancreatitis
4.420800E-01
Pancreatitis-vs-NoPancreatitis
2.574300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.787400E-01
Normal-vs-N1
4.451000E-01
N0-vs-N1
3.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.867800E-01
Normal-vs-TP53-NonMutant
5.663800E-01
TP53-Mutant-vs-TP53-NonMutant
2.22409999994788E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
